Health24.com | CRISPR Gene editing creates ‘designer’ immune cells that fight cancer

In a first, scientists have used gene-editing technology to create “designer” immune system cells that can fight tumours and survive for months in cancer patients’ bodies.

It’s a proof of principle, the researchers say – and an early step toward bringing the gene-editing tool known as CRISPR into cancer treatment.

Specific genetic mutations

CRISPR allows researchers to precisely “snip” bits of DNA within a cell and make repairs to a flawed gene or perform other alterations. For years, scientists have been developing and studying CRISPR in the lab, in part to better understand the genetics underlying various diseases.

Ultimately, though, researchers hope to use the technology to cure diseases caused by specific genetic mutations – or, in the case of cancer, to genetically arm the immune system to fight the disease.

The new findings, published online in Science, come from the first US trial to test CRISPR gene-editing in humans.

“The goal here was to see if this is safe and feasible. Can CRISPR live up to its hype?” said senior researcher Dr Carl June, a professor of immunotherapy at the University of Pennsylvania, in Philadelphia.

The initial findings suggest the answer is “yes”, he said.

The researchers were able to use CRISPR to make several specific gene edits in T cells taken from three cancer patients; T cells play a critical role in the immune system response. The modified cells were then infused into the patients, where the cells survived for months.

Exciting technology

Finally, when June’s team took samples of the T cells from the patients’ blood, they found the cells were still able to kill tumour cells in a lab dish.

Experts cautioned that much work remains.

“This research is just out of the gate,” said Dr Catherine Diefenbach, an associate professor at NYU Langone Health’s Perlmutter Cancer Center in New York City.

“The technology is exciting. This is a new way of engineering T cells to recognize tumour cells, but all they’ve shown here is that they can infuse these cells into patients, and no one got hurt,” she said.

“This is nowhere near ready for prime time,” added Diefenbach, who is also with the American Society of Clinical Oncology.

The use of T cells to fight cancer is not new. An approach called CAR T cell therapy is approved in the United States for some aggressive blood cancers. It involves removing a patient’s T cells and genetically tweaking them to sprout specific receptors on their surface. Once they are infused back into the patient, the receptors help the T cells find and destroy tumours.

New generation of ‘super T cells’

But current therapies have major limitations, said Dr Jose Conejo-Garcia, chair of immunology at Moffitt Cancer Center in Tampa, Florida.

CAR T cells only work well against blood cancers, he explained: “Solid” tumours in other types of tissue suppress the immune response against them.

In this study, June’s team used CRISPR to make three edits. The first two removed natural receptors from the T cells, so they could be reprogrammed to produce a synthetic receptor designed to help them seek and destroy tumour cells. The third edit removed a protein called PD-1, which can inhibit T cells from doing their job.

The ability to remove PD-1 “paves the way for a new generation of ‘super T cells'” that might overcome the immune-evading tricks of solid tumours, according to Conejo-Garcia, who was not involved in the research.

“Transferring genetically modified T cells is not new,” he said. “However, manipulation of multiple genes to achieve superior anti-tumour activities represents a breakthrough in the field.”

But everyone cautioned that all this study demonstrates is that the multiple gene edits are possible; the resulting T cells can survive in patients’ bodies (with the longest follow-up being nine months in one patient); and, in the lab, they can kill tumour cells.

Chromosome ‘translocation’

A critical question is: Can the edited cells do harm? Here, the researchers saw no major side effects.

But, Diefenbach stressed, much more work is needed to assess the tactic’s short- and long-term safety.

A general concern with CRISPR, June said, is the potential for “off-target” effects: Could the edited genes end up affecting the activity of other genes?

Another is chromosome “translocation” – where a piece of chromosome breaks off and attaches to another chromosome. (Translocations are a cause of some cancers.) That did happen in the T cells June’s team engineered, and some translocations persisted in patients’ bodies. But over time, June said, the frequency of those rearrangements dropped as the T cells expanded and proliferated in the blood.

The ultimate question is whether CRISPR-edited T cells can actually beat cancer back.

June predicted that it could be a decade before any such treatment advances to the point of approval.

Image credit: iStock

Share Button

Health24.com | 1 in 4 gets unnecessary antibiotics at children’s hospitals

One-quarter of kids who receive antibiotics in US children’s hospitals are given the drugs inappropriately, which increases the risk of antibiotic resistance, researchers say.

“Antibiotic resistance is a growing danger to everyone; however, there is limited data on children,” said study co-author Dr Jason Newland, a professor of paediatrics at Washington University in St. Louis.

“Data on adults have suggested that 30%-50% of antibiotics used in hospitalized adults are inappropriate,” Newland noted in a university news release.

He said the goal of the study was to determine if antibiotics used to treat hospitalised children were “suboptimal”. That means doctors shouldn’t have prescribed any antibiotics; they could have used a more effective antibiotic; or they could have prescribed a different dose or for a shorter duration.

“Health care workers must be vigilant since the inappropriate use of antibiotics is fuelling dangerous drug resistance in children,” explained Newland, who directs the antimicrobial stewardship program at St. Louis Children’s Hospital.

About one in three patients in US children’s hospitals receives one or more antibiotics, the researchers said in background notes.

They analysed data from nearly 12 000 patients at 32 US children’s hospitals. The kids were prescribed one or more antibiotics to treat or prevent infections. Of those patients, 25% – or nearly 3,600– received at least one antibiotic considered inappropriate, according to the study.

The most common cases of inappropriate antibiotic use were: giving the wrong antibiotic for a particular infection (27%); prolonged antibiotic use after surgery to prevent surgical-site infections (17%); unnecessary use of antibiotics (11%); and use of broad-spectrum antibiotics when a drug that targets a specific type of bacteria could have been used (11%).

Significant need for oversight

Pneumonia, or lower respiratory infections, accounted for the greatest percentage of suboptimal prescriptions – 18%.

The researchers also found that about half of inappropriate antibiotic use would not have been detected by current antibiotic stewardship programmes designed to prevent antibiotic resistance.

“Arguably, this is one of the most important findings because it helps us to identify blind spots in antimicrobial stewardship programmes,” Newland said.

“Antibiotics currently not targeted for review still have a significant need for oversight. The obvious solution is to expand routine reviews to include all antibiotics. Unfortunately, this is resource-intensive and may not be feasible at some hospitals,” he pointed out.

The study was recently published online in the journal Clinical Infectious Diseases.

Share Button

Surgeon suspended over treatment concerns

The doctor worked at the same private healthcare firm as rogue breast surgeon Ian Paterson.

Share Button

Egg-freezing: What’s the success rate?

The fertility expert Lord Winston warns the success rate could be as low as 1% but others say it is considerably higher.

Share Button

Facial expressions don’t tell the whole story of emotion

Interacting with other people is almost always a game of reading cues and volleying back. We think a smile conveys happiness, so we offer a smile in return. We think a frown shows sadness, and maybe we attempt to cheer that person up.

Some businesses are even working on technology to determine customer satisfaction through facial expressions.

But facial expressions might not be reliable indicators of emotion, research indicates. In fact, it might be more accurate to say we should never trust a person’s face, new research suggests.

“The question we really asked is: ‘Can we truly detect emotion from facial articulations?'” said Aleix Martinez, a professor of electrical and computer engineering at The Ohio State University.

“And the basic conclusion is, no, you can’t.”

Martinez, whose work has focused on building computer algorithms that analyze facial expressions, and his colleagues presented their findings today (Feb. 16, 2020) at the annual meeting of the American Association for the Advancement of Science in Seattle.

The researchers analyzed the kinetics of muscle movement in the human face and compared those muscle movements with a person’s emotions. They found that attempts to detect or define emotions based on a person’s facial expressions were almost always wrong.

“Everyone makes different facial expressions based on context and cultural background,” Martinez said. “And it’s important to realize that not everyone who smiles is happy. Not everyone who is happy smiles. I would even go to the extreme of saying most people who do not smile are not necessarily unhappy. And if you are happy for a whole day, you don’t go walking down the street with a smile on your face. You’re just happy.”

It is also true, Martinez said, that sometimes, people smile out of an obligation to the social norms. This would not inherently be a problem, he said — people are certainly entitled to put on a smile for the rest of the world — but some companies have begun developing technology to recognize facial muscle movements and assign emotion or intent to those movements.

The research group that presented at AAAS analyzed some of those technologies and, Martinez said, largely found them lacking.

“Some claim they can detect whether someone is guilty of a crime or not, or whether a student is paying attention in class, or whether a customer is satisfied after a purchase,” he said. “What our research showed is that those claims are complete baloney. There’s no way you can determine those things. And worse, it can be dangerous.”

The danger, Martinez said, lies in the possibility of missing the real emotion or intent in another person, and then making decisions about that person’s future or abilities.

For example, consider a classroom environment, and a teacher who assumes that a student is not paying attention because of the expression on the student’s face. The teacher might expect the student to smile and nod along if the student is paying attention. But maybe that student, for reasons the teacher doesn’t understand — cultural reasons, perhaps, or contextual ones — is listening intently, but not smiling at all. It would be, Martinez argues, wrong for the teacher to dismiss that student because of the student’s facial expressions.

After analyzing data about facial expressions and emotion, the research team — which included scientists from Northeastern University, the California Institute of Technology and the University of Wisconsin — concluded that it takes more than expressions to correctly detect emotion.

Facial color, for example, can help provide clues.

“What we showed is that when you experience emotion, your brain releases peptides — mostly hormones — that change the blood flow and blood composition, and because the face is inundated with these peptides, it changes color,” Martinez said.

The human body offers other hints, too, he said: body posture, for example. And context plays a crucial role as well.

In one experiment, Martinez showed study participants a picture cropped to display just a man’s face. The man’s mouth is open in an apparent scream; his face is bright red.

“When people looked at it, they would think, wow, this guy is super annoyed, or really mad at something, that he’s angry and shouting,” Martinez said. “But when participants saw the whole image, they saw that it was a soccer player who was celebrating a goal.”

In context, it’s clear the man is very happy. But isolate his face, Martinez said, and he appears almost dangerous.

Cultural biases play a role, too.

“In the U.S., we tend to smile a lot,” Martinez said. “We are just being friendly. But in other cultures, that means different things — in some cultures, if you walked around the supermarket smiling at everyone, you might get smacked.”

Martinez said the research group’s findings could indicate that people — from hiring managers to professors to criminal justice experts — should consider more than just a facial expression when they evaluate another person.

And while Martinez said he is “a big believer” in developing computer algorithms that try to understand social cues and the intent of a person, he added that two things are important to know about that technology.

“One is you are never going to get 100 percent accuracy,” he said. “And the second is that deciphering a person’s intent goes beyond their facial expression, and it’s important that people — and the computer algorithms they create — understand that.”

Share Button

Health24.com | Caring for grandkids might help stave off loneliness

Caring for a grandchild might be the best way to fight the isolation of old age, new research suggests.

This conclusion is based on 2014 data collected as part of an ongoing German survey of older adults.

Higher loneliness scores

Among the nearly 3 900 grandparents in the survey, more than 1 100 said they cared for a grandchild. Those who had grandchildren to care for had lower scores on loneliness and social isolation tests, and a larger social network than those who didn’t care for grandchildren.

Meanwhile, grandparents who didn’t care for a grandchild had higher loneliness scores and were in regular contact with fewer people important to them, the study authors said.

The findings were unchanged even after the researchers took into account factors such as marital status, domestic arrangements, household income, self-rated health, physical activity levels and depressive symptoms.

The study can’t prove that taking care of grandchildren by itself makes older people less lonely, only that there appears to be an association.

It might be that grandparents who felt less lonely and isolated to start with are more likely to care for a grandchild, said study author Eleanor Quirke, of the department for health economics and health services research at Hamburg-Eppendorf University Hospital, and colleagues.

Supplementary grandchild care

The study also didn’t account for how near to their grandchildren grandparents lived or how often they provided care, all of which could have affected the findings.

The report was published online in the journal BMJ Open.

“Assisting their families to balance work and family by providing supplementary grandchild care may boost grandparents’ self-esteem, and may also facilitate ongoing positive relationships with their children and grandchildren,” Quirke’s team suggested.

“Moreover, caring for grandchildren may also expand the social circle of grandparents and allow for further opportunities to establish relationships with other parents or grandparents,” the study authors explained in a journal news release.

But it’s also possible the positive effect might wear off if grandparents have to spend so much time caring for a grandchild that it interferes with their lives, the researchers added.

Image credit: iStock

Share Button

Health24.com | Scientists spot antibody that might help diagnose, treat autoimmune disorders

Researchers who have pinpointed an antibody linked to life-threatening autoimmune disorders in children say their discovery could lead to faster diagnosis and treatment of these patients.

The investigators identified the myelin oligodendrocyte glycoprotein (MOG) antibody in their study of 535 children with central nervous system demyelinating disorders and encephalitis.

MOG antibodies damage the protective covering (myelin sheath) that surrounds nerve fibres in the brain, optic nerves and spinal cord, which means that messages can’t be passed along these nerves.

Of the 116 children who tested positive for MOG antibodies and received appropriate treatment, 85% had complete or near-complete recovery, according to the study published in The Lancet Neurology journal.

MOG-antibody biomarker

The findings suggest that the MOG antibody is associated with more life-threatening autoimmune conditions than previously thought. These include neuromyelitis optica spectrum disorders and encephalitis, which cause severe brain and nervous system symptoms such as vision loss, muscle weakness and loss of coordination and speech, the researchers said.

This group of neurological disorders can mimic similar conditions like multiple sclerosis (MS), making them difficult to diagnose correctly. Until about 10 years ago, patients with these diseases were thought to have atypical forms of MS, and the prognosis and best treatment methods were unknown.

Over the last 10 years, research has shown that several demyelinating diseases are associated with the MOG-antibody biomarker, and that patients with these diseases often improve with immunotherapy.

However, the best treatment approaches and long-term outcomes remain unclear. This new study suggests that testing for the MOG antibody could help identify the most beneficial treatment for some of these disorders, the study authors said.

Difficult to distinguish

“The diagnosis of many of these patients, especially those with encephalitis, would have been missed if it were not for the prospective design of our study,” said study co-leader Thais Armangue, from Sant Joan de Deu Children’s Hospital at the University of Barcelona, in Spain.

“Identifying these patients is important because most of the children who tested positive for MOG antibodies responded to treatment with immunotherapy,” Armangue added in a journal news release.

According to study co-lead author Josep Dalmau, from the University of Barcelona, “Demyelinating diseases in children can be very difficult to distinguish because they present with similar symptoms and imaging features. Correct and early diagnosis allows for treatment with immunosuppressants, rather than the treatments specifically used in MS that are not effective. Moreover, it is important to differentiate between those diseases that do not require chronic treatment and others in which prolonged immunotherapy is needed to improve long-term outcomes.”

The study is “a milestone in the understanding of MOG antibody-associated syndromes,” Romain Marignier, from the Hopital Neurologique Pierre Wertheimer in France, wrote in an accompanying editorial.

Image credit: unsplash.com

Share Button

Health24.com | How time spent on the golf course could lengthen life

Grab your golf clubs. Spending a day on the green at least once a month may lower the risk of early death among older adults, a new study finds.

About 25 million Americans play golf, which is a sport that can reduce stress and yield exercise benefits. Social in nature and played at a controlled pace, people often continue enjoying the sport into old age.

“Our study is perhaps the first of its kind to evaluate the long-term health benefits of golf, one of the most popular sports among older people in many countries,” said lead study author Dr Adnan Qureshi. He is a professor of neurology at the University of Missouri, in Columbia.

“The US Department of Health and Human Services Physical Activity Guidelines for Americans does not yet include golf in the list of recommended physical activities,” Qureshi said in an American Heart Association news release. “Therefore, we are hopeful our research findings could help to expand the options for adults to include golf.”

For the study, researchers analysed data from the Cardiovascular Health Study, which had examined risk factors for heart disease and stroke in adults aged 65 and older. Nearly 5 900 participants with an average age of 72 were studied. Out of all of these patients, 384 were identified as golfers.

During follow-up, 8% of golfers suffered strokes and nearly 10% had heart attacks. When comparing the death rates, golfers had a significantly lower rate of death – 15 percent compared to just under 25% of non-golfers. However, the study did not prove that golfing itself boosts longevity.

Something for older adults

“While walking and low-intensity jogging may be comparable exercise, they lack the competitive excitement of golf,” Qureshi explained.

“Regular exercise, exposure to a less polluted environment and social interactions provided by golf are all positive for health,” he added. “Another positive is that older adults can continue to play golf, unlike other more strenuous sports such as football, boxing and tennis.”

The findings are to be presented next week at the American Stroke Association’s International Stroke Conference, in Los Angeles. Such research is considered preliminary until published in a peer-reviewed medical journal.

The researchers are performing more analyses to determine whether playing golf might counter other health conditions.

Image credit: iStock

Share Button

Young onset Parkinson’s disease surgery gives Luton man ‘lifeline’

The disease, which normally affects people later in life, forced Ryan to make a “scary” decision.

Share Button

Health24.com | How low levels of key blood cells could signal higher death risk

A condition called lymphopenia – low levels of lymphocyte blood cells – could be an early warning for illness, a new study suggests.

Danish researchers linked the condition to a 60% increased risk of death from any cause during the study period.

Falling lymphocyte levels

A low lymphocyte count was also associated with a 1.5- to 2.8-fold increased risk of death from cancer, heart disease, respiratory disease, infections and other causes.

The findings come from an analysis of data from more than 108 000 people in Denmark, aged 20 to 100, between 2003 and 2015.

Older age was associated with falling lymphocyte levels, the study authors said in the report published in the CMAJ (Canadian Medical Association Journal).

The researchers suggested that the link between lymphopenia and death risk may stem from a reduced ability of the immune system to fight serious diseases.

Lymphopenia could also be an indication of frailty, which increases the risk of illness and death, the study authors noted.

Additional surveillance

“Our study showed that participants with lymphopenia were at high risk of dying from any cause, regardless of any other risk factor for all-cause mortality including age,” according to Dr Stig Bojesen and colleagues. Bojesen is a clinical professor at Herlev-Gentofte Hospital in Herlev, Denmark.

Lymphopenia is often detected during routine blood tests, but patients typically aren’t referred for follow-up because its usefulness as a predictor of future health wasn’t known, the authors said in a journal news release.

The new findings may help doctors identify at-risk people, the team added.

“Using the absolute two-year risks of all-cause mortality, physicians can identify high-risk individuals with lymphopenia (e.g., smokers older than 80 years) who might benefit from additional surveillance,” Bojesen and colleagues concluded.

Image credit: iStock

Share Button